US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Axsome Therapeutics

100.69

-2.2000-2.14%

Post-market: 100.690.00000.00%17:11 EDT

Volume:1.15M

Turnover:115.70M

Market Cap:4.97B

PE:-17.45

High:103.92

Open:102.43

Low:99.98

Close:102.89

Loading ...

Overview Company News Filings

Mizuho Securities Adjusts Axsome Therapeutics Price Target to $212 From $195, Maintains Outperform Rating

MT Newswires Live

Buy Rating for Axsome Therapeutics Driven by Promising SYMBRAVO Phase 3 Trial Results

Axsome Therapeutics Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs

Axsome Therapeutics’ Symbravo: A Promising Alternative in the Migraine Treatment Market

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Analysts’ Top Healthcare Picks: MiMedx Group (MDXG), Axsome Therapeutics (AXSM)

BUZZ-Axsome Therapeutics rises on migraine drug trial data

Axsome Therapeutics Price Target Maintained With a $153.00/Share by Needham

Axsome Therapeutics Says Migraine Drug Symbravo Achieves Primary Endpoint in Phase 3 Trial

MT Newswires Live

Axsome Therapeutics says SYMBRAVO achieves primary endpoint in EMERGE trial

Axsome Therapeutics Inc - Symbravo Shows Greater Migraine Treatment Response Than Oral Cgrp Inhibitors

THOMSON REUTERS

Axsome Therapeutics Announces Symbravo® (Meloxicam and Rizatriptan) Achieves Primary Endpoint in the Emerge Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral Cgrp Inhibitors

THOMSON REUTERS

Axsome Therapeutics Inc - Symbravo Well Tolerated With Consistent Safety Profile

THOMSON REUTERS

Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intra-Cellular Therapies (ITCI), Axsome Therapeutics (AXSM) and Merck & Company (MRK)

Why Axsome Therapeutics, Inc. (AXSM) is the Best Performing Pharma Stock So Far in 2025

Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Walgreens Boots Alliance (WBA) and Axsome Therapeutics (AXSM)

Stock Track | Axsome Therapeutics Soars 5.02% as Analyst Cites Optimistic Long-Term Prospects

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AXSM/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AXSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics","latestPrice":100.69,"timestamp":1750449600000,"preClose":102.89,"halted":0,"volume":1146016,"hourTrading":{"tag":"盘后","latestPrice":100.69,"preClose":100.69,"latestTime":"17:11 EDT","volume":263478,"amount":26554453.69974,"timestamp":1750453906988},"delay":0,"floatShares":38424988,"shares":49376365,"eps":-5.769904,"marketStatus":"Post-Mkt","change":-2.2,"latestTime":"06-20 18:38:01 EDT","open":102.43,"high":103.915,"low":99.98,"amount":115697592.4016,"amplitude":0.038245,"askPrice":105,"askSize":40,"bidPrice":100.09,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-5.769904,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750464000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1447909200000,"exchange":"NASDAQ","adjPreClose":102.89,"preHourTrading":{"tag":"盘前","latestPrice":103,"preClose":102.89,"latestTime":"09:27 EDT","volume":1134,"amount":116704.43064,"timestamp":1750426060083},"postHourTrading":{"tag":"盘后","latestPrice":100.69,"preClose":100.69,"latestTime":"17:11 EDT","volume":263478,"amount":26554453.69974,"timestamp":1750453906988},"volumeRatio":1.773284,"impliedVol":0.3245,"impliedVolPercentile":0.024},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AXSM\",,,,,undefined,":{"symbol":"AXSM","floatShares":38424988,"roa":"-26.18%","roe":"-282.16%","lyrEps":-5.994374,"volumeRatio":1.773284,"shares":49376365,"dividePrice":0,"high":103.915,"amplitude":0.038245,"preClose":102.89,"low":99.98,"week52Low":72.02,"pbRate":"93.44","psRate":"11.50","week52High":139.1299,"institutionHeld":0,"latestPrice":100.69,"eps":-5.769904,"divideRate":0,"volume":1146016,"delay":0,"ttmEps":-5.769904,"open":102.43,"prevYearClose":84.61,"prevWeekClose":104.1,"prevMonthClose":105.16,"prevQuarterClose":116.63,"fiveDayClose":106.25,"twentyDayClose":105.76,"sixtyDayClose":120.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AXSM\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514830282","title":"Mizuho Securities Adjusts Axsome Therapeutics Price Target to $212 From $195, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514830282","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514830282?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:33","pubTimestamp":1740576822,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) has an average rating of Buy and mean price target of $167.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AXSM","MFG"],"gpt_icon":0},{"id":"2514067953","title":"Buy Rating for Axsome Therapeutics Driven by Promising SYMBRAVO Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514067953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514067953?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:16","pubTimestamp":1740482207,"startTime":"0","endTime":"0","summary":"Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), retaining the price target of $20...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-axsome-therapeutics-driven-by-promising-symbravo-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-axsome-therapeutics-driven-by-promising-symbravo-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM"],"gpt_icon":0},{"id":"2514694777","title":"Axsome Therapeutics Full Year 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2514694777","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514694777?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:36","pubTimestamp":1740422215,"startTime":"0","endTime":"0","summary":"NasdaqGM:AXSM Revenue and Expenses Breakdown February 24th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 9.5%.The primary driver behind last 12 months revenue was the United States segment contributing a total revenue of US$378.2m . The largest operating expense was General & Administrative costs, amounting to US$310.2m . Explore how AXSM's revenue and expenses shape its earnings.Looking ahead, revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Pharmaceuticals industry in the US.The company's shares are up 5.0% from a week ago.While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Axsome Therapeutics' balance sheet.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-therapeutics-full-2024-earnings-183655619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AXSM"],"gpt_icon":0},{"id":"2514722057","title":"Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514722057","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514722057?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:34","pubTimestamp":1740422062,"startTime":"0","endTime":"0","summary":"On Monday, Axsome Therapeutics, Inc. announced that the EMERGE Phase 3 trial of Symbravo in patients experiencing inadequate response to oral CGRP inhibitors  met its primary endpoint.Symbravo demonstrated statistically significantly greater migraine treatment response than oral CGRP inhibitors, as measured by the Migraine Treatment Optimization Questionnaire  .Also Read: Axsome’s AXS-05 In Alzheimer’s Agitation Could Be Billion Dollar Opportunity, Says Analyst. In the trial, Symbravo rapidly and substantially improved migraine pain and most bothersome symptoms.Pain freedom within 2 hours for most attacks was reported half the time or more by 47.9% of patients after treatment with Symbravo, compared to 1.0% of patients after treatment with oral CGRPs.The ability to quickly return to normal activities after taking their medication was reported half the time or more by 51.0% of patients after treatment with Symbravo, compared to 11.5% of patients after treatment with oral CGRPs.This arti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-says-symbravo-hits-primary-183422632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AXSM","BK4007","BK4505","BK4585","SSI"],"gpt_icon":0},{"id":"2514077206","title":"Axsome Therapeutics’ Symbravo: A Promising Alternative in the Migraine Treatment Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2514077206","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514077206?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:25","pubTimestamp":1740421517,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on AXSM stock, giving a Buy rating today. Myles Minter has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-symbravo-a-promising-alternative-in-the-migraine-treatment-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-symbravo-a-promising-alternative-in-the-migraine-treatment-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AXSM","BK4505","BK4585"],"gpt_icon":0},{"id":"2513733767","title":"BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities","url":"https://stock-news.laohu8.com/highlight/detail?id=2513733767","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513733767?lang=en_us&edition=fundamental","pubTime":"2025-02-24 23:46","pubTimestamp":1740412013,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF15L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775H168.HKD","LU0594300419.USD","BRDG","TUYA","AXSM","LU2750360997.AUD","MACW.SI","YYAI","LU0823397103.USD","IVVD","SUI","LU1769817179.HKD","WING","U","CEG","LU1778281490.HKD","BCRX","SMCI","PLTR","FDP","LU0198837287.USD","AMRX","CTAS","ZH","SMMT","LU2756315318.SGD","AGIO","BBWI","CRL","ARMK","OC","GFI","NKE","TWLO","AAPL","LU0345770993.USD","ABR","HE","AZUL","GOOS","PODD","BMRN","PDD","AU","LU0823434740.USD","DPZ","TRDA","XYZ","LU1981816686.USD","HOOD"],"gpt_icon":0},{"id":"2513722885","title":"BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722885","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722885?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:25","pubTimestamp":1740407154,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Twilio, Bath & Body Works, WingstopEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL6N3PF0C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDU","LU2552382058.USD","ARMK","BBWI","LU1303367103.USD","SNVD.UK","ABR","TWLO","SG9999001176.USD","CTAS","LU1162221912.USD","LU0211331839.USD","2NVD.UK","WING","PODD","3NVD.UK","NVDS","NVD2.UK","AMRX","BRDG","NVD3.UK","NVDS.UK","AGIO","FDP","DPZ","NVDY","LU0788109477.HKD","LU2097344357.USD","OC","AXSM","AU","LU1923622614.USD","MACW.SI","LU1718418525.SGD","IE00B2PGVK34.USD","NVIW.SI","NVDD","SMMT","NVDX","NVD","IVVD","TRDA"],"gpt_icon":1},{"id":"2513724395","title":"Analysts’ Top Healthcare Picks: MiMedx Group (MDXG), Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724395","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724395?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:00","pubTimestamp":1740405656,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on MiMedx Group (MDXG – Research Report), Axsome Therap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-mimedx-group-mdxg-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-mimedx-group-mdxg-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AXSM","BK4007","BK4585","HCSG","BK4505","MDXG","BK4137"],"gpt_icon":0},{"id":"2513721083","title":"BUZZ-Axsome Therapeutics rises on migraine drug trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2513721083","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513721083?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:59","pubTimestamp":1740405590,"startTime":"0","endTime":"0","summary":"BUZZ-Axsome Therapeutics rises on migraine drug trial data** Drugmaker Axsome Therapeutics' AXSM.O shares rise 1.6% to $139.98 premarket** AXSM says its drug, Symbravo, met the main goal in a late-stage trial to treat migraine headaches in patients who didn't respond well to other treatments** Symbravo is a combination of two medicines, meloxicam and rizatriptan** In the trial, Symbravo was found to be more effective than oral CGRP inhibitors in relieving migraine pain, with 47.9% of patients pain-free within 2 hours, compared with only 1% of patients who took oral CGRP inhibitors, the company says** Symbravo is not recommended for people with heart problems, high blood pressure, or kidney disease, or for pregnant or breastfeeding women** AXSM gained 6.3% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF0VU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AXSM","BK4505","BK4007"],"gpt_icon":0},{"id":"2513745724","title":"Axsome Therapeutics Price Target Maintained With a $153.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2513745724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513745724?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:59","pubTimestamp":1740405540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 08:59 ET (13:59 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXSM"],"gpt_icon":0},{"id":"2513725237","title":"Axsome Therapeutics Says Migraine Drug Symbravo Achieves Primary Endpoint in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2513725237","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513725237?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:58","pubTimestamp":1740401884,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  said Monday that its migraine drug Symbravo achieved the primary endpoint in a phase three trial, showing statistically significant improvements in overall quality of life and daily functioning compared with oral calcitonin gene-related peptide, or CGRP inhibitors, as measured by the Migraine-Specific Quality of Life Questionnaire.The trial showed that 47.9% of patients achieved pain freedom within two hours with Symbravo compared with 1% on oral CGRP inhibitors, the company said. Additionally, 47.9% sustained pain relief from migraine for at least 24 hours with Symbravo versus 16.7% with CGRP inhibitors.The trial also demonstrated that 51% of patients after treatment with Symbravo were able to resume normal activities quickly, compared to 11.5% on oral CGRP inhibitors, Axsome said.Axsome said Symbravo was \"well tolerated\", with the most common adverse events being fatigue, nausea, vomiting, muscle tightness, and dizziness.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4585","BK4505","AXSM"],"gpt_icon":0},{"id":"2513723375","title":"Axsome Therapeutics says SYMBRAVO achieves primary endpoint in EMERGE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723375","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723375?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:22","pubTimestamp":1740399777,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (AXSM) announced that the EMERGE Phase 3 trial of SYMBRAVO in patients experiencing inadequate response to oral CGRP inhibitors...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-says-symbravo-achieves-primary-endpoint-in-emerge-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/axsome-therapeutics-says-symbravo-achieves-primary-endpoint-in-emerge-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AXSM","BK4505","BK4007","BK4585"],"gpt_icon":0},{"id":"2513740658","title":"Axsome Therapeutics Inc - Symbravo Shows Greater Migraine Treatment Response Than Oral Cgrp Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2513740658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513740658?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA1WPDVP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","BK4007","AXSM"],"gpt_icon":0},{"id":"2513681740","title":"Axsome Therapeutics Announces Symbravo® (Meloxicam and Rizatriptan) Achieves Primary Endpoint in the Emerge Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral Cgrp Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2513681740","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513681740?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA1WPDVP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4505","BK4585","BK4007"],"gpt_icon":0},{"id":"2513670740","title":"Axsome Therapeutics Inc - Symbravo Well Tolerated With Consistent Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2513670740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513670740?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA1WPDVP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","BK4505","AXSM"],"gpt_icon":0},{"id":"2513372803","title":"Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2513372803","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513372803?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"SYMBRAVO demonstrated statistically significantly greater migraine treatment response compared to prior treatment with an oral CGRP inhibitor . 2-hour pain freedom for most attacks reported at least half the time by 47.9% of patients after SYMBRAVO versus 1.0% after oral CGRPs . 24-hour or greater sustained pain relief after a single dose reported by 47.9% of patients after SYMBRAVO versus 16.7% after oral CGRPs . Ability to quickly return to normal activities reported by 51.0% of patients after SYMBRAVO versus 11.5% after oral CGRPs . SYMBRAVO improved quality of life compared to after oral CGRPs . EMERGE met the primary endpoint by demonstrating statistically significantly greater migraine treatment response with SYMBRAVO compared to treatment response with prior oral CGRP inhibitors, as assessed by the mTOQ-4 total score . Statistically significantly greater proportions of patients achieved clinical response on the 2-hour pain freedom, sustained pain freedom, ability to return to no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-therapeutics-announces-symbravo-meloxicam-120000644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4135","BK4007","BK4585","BK4588","BK4023","IHS","HCP","BK4115","CNS","AXSM"],"gpt_icon":0},{"id":"2513767709","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Intra-Cellular Therapies (ITCI), Axsome Therapeutics (AXSM) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513767709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513767709?lang=en_us&edition=fundamental","pubTime":"2025-02-24 09:20","pubTimestamp":1740360039,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intra-Cellular Therapies (ITCI – Research Report), Axsome Therape...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-intra-cellular-therapies-itci-axsome-therapeutics-axsm-and-merck-company-mrk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-intra-cellular-therapies-itci-axsome-therapeutics-axsm-and-merck-company-mrk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0861579265.USD","IE00BLSP4452.SGD","LU0965509010.AUD","LU2023250843.SGD","HCSG","LU1116320737.USD","LU0006306889.USD","SG9999001176.USD","LU1989771016.USD","LU0058720904.USD","LU2361044949.HKD","LU0965508806.USD","LU1037948541.HKD","IE00BJT1NW94.SGD","IE000M9KFDE8.USD","LU0109394709.USD","LU0985320562.USD","BK4007","LU2106854487.HKD","SGXZ57979304.SGD","LU0889565916.HKD","LU1066051498.USD","LU1585245621.USD","LU1066051811.HKD","IE0009355771.USD","SG9999014567.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU1974910355.USD","SG9999014575.USD","LU1061106388.HKD","SG9999014542.SGD","LU2112291526.USD","LU1929549753.HKD","AXSM","LU1989772840.SGD","LU0265550946.USD","ITCI","MRK","LU0106261372.USD","LU0012050646.USD","LU1941712264.USD","LU1934455277.USD","IE00BBT3K403.USD","SG9999015358.SGD","LU0265550359.USD","SG9999002224.SGD","LU1057294990.SGD","IE00B2B36J28.USD","BK4559"],"gpt_icon":0},{"id":"2513508027","title":"Why Axsome Therapeutics, Inc. (AXSM) is the Best Performing Pharma Stock So Far in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513508027","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513508027?lang=en_us&edition=fundamental","pubTime":"2025-02-24 04:09","pubTimestamp":1740341380,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Axsome Therapeutics, Inc.  stands against the other best performing pharma stocks so far in 2025.On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on ‘Squawk Box’ to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump administration. Talking about the pharma’s agenda in Washington, where the big names of the pharma industry were set to meet with President Trump on February 20, Holz said that while it is tough to talk about the valuation of pharma companies, the significance of the meeting is to have a sort of collaborative effort between the industry and the government to see where they can move things over time. The stocks have exhibited either a little bit or a lot of worry over the RFK front, the United States Secretary of Health and Human Services. This was based on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-axsome-therapeutics-inc-axsm-200940977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","PSQ","USJW.SI","AXSM","SQQQ","TSYW.SI","BK4007","TQQQ","MNQmain","BK4505","QID","NQmain","NVIW.SI","BK4585",".IXIC","QLD"],"gpt_icon":1},{"id":"2513734673","title":"Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Walgreens Boots Alliance (WBA) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513734673","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513734673?lang=en_us&edition=fundamental","pubTime":"2025-02-23 19:10","pubTimestamp":1740309045,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Halozyme (HALO – Research Report), Walgreens Boots Alliance (WBA ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-halozyme-halo-walgreens-boots-alliance-wba-and-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-halozyme-halo-walgreens-boots-alliance-wba-and-axsome-therapeutics-axsm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0321505868.SGD","AXSM","BK4585","BK4139","HALO","LU0053671581.USD","BK4588","WBA","BK4007","BK4128","HCSG","LU0321505439.SGD","BK4505"],"gpt_icon":0},{"id":"1167850716","title":"Stock Track | Axsome Therapeutics Soars 5.02% as Analyst Cites Optimistic Long-Term Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1167850716","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167850716?lang=en_us&edition=fundamental","pubTime":"2025-02-22 00:30","pubTimestamp":1740155426,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics  stock surged 5.02% on Friday during the trading session, reflecting investors' optimism about the company's long-term prospects.Mizuho Securities analyst Graig Suvannavejh maintained a bullish stance on AXSM, reiterating a Buy rating on the stock. The analyst cited strong sales and strategic pipeline developments as key factors driving the optimistic outlook for Axsome Therapeutics.Suvannavejh highlighted the company's robust commercial execution and potential for further gr","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Axsome Therapeutics Soars 5.02% as Analyst Cites Optimistic Long-Term Prospects","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AXSM"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AXSM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-05","symbol":"AXSM","fiscalQuarterEnding":"2025/03","expectedEps":-1.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2025-02-18","symbol":"AXSM","fiscalQuarterEnding":"2024/12","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739854800000,"reportTimeType":"pre","actualEps":-0.96},{"market":"US","date":"2025-01-13","symbol":"AXSM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-12","symbol":"AXSM","fiscalQuarterEnding":"2024/09","expectedEps":-1.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.34},{"market":"US","date":"2024-08-05","symbol":"AXSM","fiscalQuarterEnding":"2024/06","expectedEps":-1.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-1.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AXSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AXSM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.6316,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6316,"analysts":19,"updateTime":1749528000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AXSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AXSM","date":"2025-06-18","current":-18.027824,"percent":0.439935,"low":-46.566543,"twenty":-21.978884,"median":-16.742979,"eighty":-12.087351,"high":-6.009438,"avg":-18.013341,"sd":7.388965,"marketCap":5016638684},"quantilePoints":[{"date":"2020-06-26","current":-46.539419,"twenty":-23.453022,"median":-9.194644,"eighty":-3.347892,"marketCap":3180745235},{"date":"2020-07-02","current":-43.924662,"twenty":-23.537303,"median":-9.195895,"eighty":-3.355422,"marketCap":3002039185},{"date":"2020-07-10","current":-45.047597,"twenty":-23.575997,"median":-9.252351,"eighty":-3.360692,"marketCap":3078786389},{"date":"2020-07-17","current":-44.293549,"twenty":-23.688243,"median":-9.27672,"eighty":-3.360692,"marketCap":3027250827},{"date":"2020-07-24","current":-41.960882,"twenty":-23.79365,"median":-9.359006,"eighty":-3.361445,"marketCap":2867824268},{"date":"2020-07-31","current":-38.695148,"twenty":-23.90843,"median":-9.369936,"eighty":-3.364772,"marketCap":2644627085},{"date":"2020-08-07","current":-42.351468,"twenty":-24.001264,"median":-9.445345,"eighty":-3.367789,"marketCap":2894518948},{"date":"2020-08-14","current":-31.085393,"twenty":-24.144138,"median":-9.496431,"eighty":-3.374808,"marketCap":2945457014},{"date":"2020-08-21","current":-30.522708,"twenty":-24.239696,"median":-9.535186,"eighty":-3.37804,"marketCap":2892140513},{"date":"2020-08-28","current":-29.987567,"twenty":-24.493059,"median":-9.615634,"eighty":-3.390967,"marketCap":2841433911},{"date":"2020-09-04","current":-26.890832,"twenty":-24.785116,"median":-9.672397,"eighty":-3.390967,"marketCap":2548006738},{"date":"2020-09-11","current":-28.736281,"twenty":-25.060244,"median":-9.751865,"eighty":-3.390967,"marketCap":2722869945},{"date":"2020-09-18","current":-32.12813,"twenty":-25.208723,"median":-9.865391,"eighty":-3.390967,"marketCap":3044260318},{"date":"2020-09-25","current":-30.30629,"twenty":-26.023431,"median":-10.00765,"eighty":-3.390967,"marketCap":2871634167},{"date":"2020-10-02","current":-27.740762,"twenty":-26.53307,"median":-10.090701,"eighty":-3.390967,"marketCap":2628540753},{"date":"2020-10-09","current":-29.354054,"twenty":-27.382689,"median":-10.228673,"eighty":-3.416217,"marketCap":2781406243},{"date":"2020-10-16","current":-29.015656,"twenty":-28.035876,"median":-10.330949,"eighty":-3.42888,"marketCap":2749341774},{"date":"2020-10-23","current":-28.087029,"twenty":-28.082185,"median":-10.398962,"eighty":-3.42888,"marketCap":2661350907},{"date":"2020-10-30","current":-26.092055,"twenty":-28.035876,"median":-10.444372,"eighty":-3.440834,"marketCap":2472319678},{"date":"2020-11-06","current":-25.564895,"twenty":-28.035876,"median":-10.489783,"eighty":-3.440834,"marketCap":2519239799},{"date":"2020-11-13","current":-28.111531,"twenty":-28.035876,"median":-10.687485,"eighty":-3.440834,"marketCap":2770192830},{"date":"2020-11-20","current":-27.452134,"twenty":-28.082185,"median":-10.932533,"eighty":-3.440834,"marketCap":2705213920},{"date":"2020-11-27","current":-28.490495,"twenty":-28.083154,"median":-11.119611,"eighty":-3.45465,"marketCap":2807537031},{"date":"2020-12-04","current":-30.339838,"twenty":-28.091929,"median":-11.258606,"eighty":-3.484182,"marketCap":2989776732},{"date":"2020-12-11","current":-30.059405,"twenty":-28.419132,"median":-11.329873,"eighty":-3.490702,"marketCap":2962142023},{"date":"2020-12-18","current":-29.661493,"twenty":-28.560787,"median":-11.457113,"eighty":-3.490702,"marketCap":2922930612},{"date":"2020-12-24","current":-32.177812,"twenty":-28.75014,"median":-11.558574,"eighty":-3.490702,"marketCap":3170896106},{"date":"2020-12-31","current":-30.874177,"twenty":-28.947976,"median":-11.582928,"eighty":-3.498176,"marketCap":3042432055},{"date":"2021-01-08","current":-29.449273,"twenty":-29.095272,"median":-11.714853,"eighty":-3.516148,"marketCap":2902017859},{"date":"2021-01-15","current":-29.085468,"twenty":-29.198234,"median":-11.798821,"eighty":-3.532002,"marketCap":2866167426},{"date":"2021-01-22","current":-28.289644,"twenty":-29.165155,"median":-11.860918,"eighty":-3.540569,"marketCap":2787744604},{"date":"2021-01-29","current":-25.803642,"twenty":-29.16126,"median":-11.953582,"eighty":-3.54161,"marketCap":2542766646},{"date":"2021-02-05","current":-28.517022,"twenty":-29.142048,"median":-12.324236,"eighty":-3.552989,"marketCap":2810151125},{"date":"2021-02-12","current":-28.282065,"twenty":-29.117759,"median":-12.416899,"eighty":-3.583568,"marketCap":2786997720},{"date":"2021-02-19","current":-27.38771,"twenty":-29.085468,"median":-12.602226,"eighty":-3.590436,"marketCap":2698865406},{"date":"2021-02-26","current":-25.526998,"twenty":-29.049432,"median":-12.694889,"eighty":-3.590436,"marketCap":2515505379},{"date":"2021-03-05","current":-23.635339,"twenty":-29.023526,"median":-12.694889,"eighty":-3.613962,"marketCap":2432090525},{"date":"2021-03-12","current":-24.169696,"twenty":-29.015656,"median":-12.940357,"eighty":-3.730855,"marketCap":2487076269},{"date":"2021-03-19","current":-23.482665,"twenty":-28.846457,"median":-13.52886,"eighty":-3.760079,"marketCap":2416380312},{"date":"2021-03-26","current":-21.534258,"twenty":-28.838588,"median":-13.621523,"eighty":-3.76982,"marketCap":2215888076},{"date":"2021-04-01","current":-20.901753,"twenty":-28.78446,"median":-13.760518,"eighty":-3.76982,"marketCap":2150802910},{"date":"2021-04-09","current":-19.262328,"twenty":-28.770928,"median":-13.971843,"eighty":-3.76982,"marketCap":1982105151},{"date":"2021-04-16","current":-19.425907,"twenty":-28.764865,"median":-14.131173,"eighty":-3.800991,"marketCap":1998937521},{"date":"2021-04-23","current":-19.307504,"twenty":-28.757285,"median":-14.335102,"eighty":-3.816578,"marketCap":1986753718},{"date":"2021-04-30","current":-22.070934,"twenty":-28.740179,"median":-14.508939,"eighty":-3.818526,"marketCap":2271112305},{"date":"2021-05-07","current":-20.793258,"twenty":-28.736281,"median":-14.681183,"eighty":-3.818526,"marketCap":2139638718},{"date":"2021-05-14","current":-22.019873,"twenty":-28.701655,"median":-14.801134,"eighty":-3.818526,"marketCap":2194862183},{"date":"2021-05-21","current":-20.870256,"twenty":-28.655296,"median":-14.864222,"eighty":-3.826319,"marketCap":2080272494},{"date":"2021-05-28","current":-22.883028,"twenty":-28.636775,"median":-14.92072,"eighty":-3.83606,"marketCap":2280898376},{"date":"2021-06-04","current":-23.112951,"twenty":-28.62768,"median":-15.069857,"eighty":-3.849697,"marketCap":2303816314},{"date":"2021-06-11","current":-25.023953,"twenty":-28.565893,"median":-15.2723,"eighty":-3.85749,"marketCap":2494298192},{"date":"2021-06-18","current":-25.3858,"twenty":-28.525855,"median":-15.395896,"eighty":-3.892558,"marketCap":2530365766},{"date":"2021-06-25","current":-27.70388,"twenty":-28.520054,"median":-15.583979,"eighty":-3.962694,"marketCap":2761423665},{"date":"2021-07-02","current":-24.89203,"twenty":-28.501106,"median":-15.829585,"eighty":-4.001321,"marketCap":2481148555},{"date":"2021-07-09","current":-24.620645,"twenty":-28.488077,"median":-16.072993,"eighty":-4.020803,"marketCap":2454097874},{"date":"2021-07-16","current":-20.436794,"twenty":-28.467162,"median":-16.281692,"eighty":-4.296588,"marketCap":2037066545},{"date":"2021-07-23","current":-20.233255,"twenty":-28.441204,"median":-16.586109,"eighty":-4.680907,"marketCap":2016778535},{"date":"2021-07-30","current":-18.314715,"twenty":-28.433613,"median":-16.793478,"eighty":-4.685848,"marketCap":1825545250},{"date":"2021-08-06","current":-19.283408,"twenty":-28.418818,"median":-17.12943,"eighty":-4.706221,"marketCap":1922101152},{"date":"2021-08-13","current":-7.580584,"twenty":-28.417086,"median":-16.637241,"eighty":-4.716408,"marketCap":861409331},{"date":"2021-08-20","current":-7.149492,"twenty":-28.417086,"median":-16.132105,"eighty":-4.716408,"marketCap":812422798},{"date":"2021-08-27","current":-7.958618,"twenty":-28.417086,"median":-15.583979,"eighty":-4.716408,"marketCap":904366752},{"date":"2021-09-03","current":-8.850647,"twenty":-28.417086,"median":-15.2723,"eighty":-4.716408,"marketCap":1005731192},{"date":"2021-09-10","current":-9.082773,"twenty":-28.417086,"median":-14.928377,"eighty":-4.716408,"marketCap":1032108555},{"date":"2021-09-17","current":-9.855422,"twenty":-28.417086,"median":-14.839801,"eighty":-4.716408,"marketCap":1119907494},{"date":"2021-09-24","current":-11.075744,"twenty":-28.417086,"median":-14.51997,"eighty":-4.716408,"marketCap":1258577063},{"date":"2021-10-01","current":-11.36756,"twenty":-28.417086,"median":-14.177504,"eighty":-4.716408,"marketCap":1291737177},{"date":"2021-10-08","current":-10.677813,"twenty":-28.417086,"median":-13.899514,"eighty":-4.716408,"marketCap":1213358725},{"date":"2021-10-15","current":-13.297524,"twenty":-28.417086,"median":-13.602473,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-22","current":-13.297524,"twenty":-28.417086,"median":-13.469961,"eighty":-4.716408,"marketCap":1511046114},{"date":"2021-10-29","current":-12.76695,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":1450754998},{"date":"2021-11-05","current":-13.330685,"twenty":-28.417086,"median":-13.115139,"eighty":-4.716408,"marketCap":1514814309},{"date":"2021-11-12","current":-11.782465,"twenty":-28.417086,"median":-12.97288,"eighty":-4.716408,"marketCap":1479777437},{"date":"2021-11-19","current":-10.744071,"twenty":-28.417086,"median":-12.694889,"eighty":-4.716408,"marketCap":1349364041},{"date":"2021-11-26","current":-11.080198,"twenty":-28.417086,"median":-12.602226,"eighty":-4.716408,"marketCap":1391578782},{"date":"2021-12-03","current":-9.675666,"twenty":-28.417086,"median":-12.509562,"eighty":-4.716408,"marketCap":1215181471},{"date":"2021-12-10","current":-9.94877,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1249480948},{"date":"2021-12-17","current":-10.594014,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1330518174},{"date":"2021-12-23","current":-11.539372,"twenty":-28.417086,"median":-12.235636,"eighty":-4.716408,"marketCap":1449247133},{"date":"2021-12-31","current":-11.338296,"twenty":-28.417086,"median":-11.768255,"eighty":-4.716408,"marketCap":1423993672},{"date":"2022-01-07","current":-9.876742,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1240434933},{"date":"2022-01-14","current":-8.583252,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1077983563},{"date":"2022-01-21","current":-7.114196,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":893482530},{"date":"2022-01-28","current":-7.898993,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":992046412},{"date":"2022-02-04","current":-8.616265,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1082129654},{"date":"2022-02-11","current":-9.621646,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1208396959},{"date":"2022-02-18","current":-8.874363,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1114544544},{"date":"2022-02-25","current":-8.460206,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1062529953},{"date":"2022-03-04","current":-8.825214,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1150834298},{"date":"2022-03-11","current":-9.674984,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1261646828},{"date":"2022-03-18","current":-9.916932,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1293197618},{"date":"2022-03-25","current":-10.433285,"twenty":-28.415355,"median":-11.543874,"eighty":-4.726594,"marketCap":1360531621},{"date":"2022-04-01","current":-12.95604,"twenty":-28.415355,"median":-11.795362,"eighty":-4.726594,"marketCap":1689506320},{"date":"2022-04-08","current":-12.00595,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1565611755},{"date":"2022-04-14","current":-10.875874,"twenty":-28.415355,"median":-12.224063,"eighty":-4.726594,"marketCap":1418246480},{"date":"2022-04-22","current":-11.667797,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1521515699},{"date":"2022-04-29","current":-9.47449,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1235501878},{"date":"2022-05-06","current":-8.242936,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1160402061},{"date":"2022-05-13","current":-7.712204,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1085688045},{"date":"2022-05-20","current":-8.74879,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1231613857},{"date":"2022-05-27","current":-7.314154,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":1029652533},{"date":"2022-06-03","current":-7.057081,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":993462931},{"date":"2022-06-10","current":-6.730902,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":947544942},{"date":"2022-06-17","current":-6.272039,"twenty":-28.415355,"median":-12.28155,"eighty":-4.726594,"marketCap":882948449},{"date":"2022-06-24","current":-6.761308,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":951825433},{"date":"2022-07-01","current":-11.233834,"twenty":-28.417086,"median":-12.327465,"eighty":-4.716408,"marketCap":1581446672},{"date":"2022-07-08","current":-12.604892,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1774457880},{"date":"2022-07-15","current":-12.076924,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1700132999},{"date":"2022-07-22","current":-11.142614,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1568605200},{"date":"2022-07-29","current":-10.667166,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1501673894},{"date":"2022-08-05","current":-12.007818,"twenty":-28.417086,"median":-12.531507,"eighty":-4.716408,"marketCap":1690404612},{"date":"2022-08-12","current":-12.438313,"twenty":-28.417086,"median":-12.604892,"eighty":-4.716408,"marketCap":1864871817},{"date":"2022-08-19","current":-16.008246,"twenty":-28.417086,"median":-12.734015,"eighty":-4.716408,"marketCap":2400110584},{"date":"2022-08-26","current":-19.19834,"twenty":-28.417086,"median":-13.012341,"eighty":-4.716408,"marketCap":2878400274},{"date":"2022-09-02","current":-18.014352,"twenty":-28.417086,"median":-13.144984,"eighty":-4.716408,"marketCap":2700885345},{"date":"2022-09-09","current":-17.751244,"twenty":-28.417086,"median":-13.297524,"eighty":-4.716408,"marketCap":2661437584},{"date":"2022-09-16","current":-16.93046,"twenty":-28.417086,"median":-13.546231,"eighty":-4.716408,"marketCap":2538377718},{"date":"2022-09-23","current":-14.373731,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":2155048380},{"date":"2022-09-30","current":-12.760762,"twenty":-28.417086,"median":-13.785155,"eighty":-4.716408,"marketCap":1913216449},{"date":"2022-10-07","current":-13.103947,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1964670051},{"date":"2022-10-14","current":-13.7274,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":2058144096},{"date":"2022-10-21","current":-11.862761,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1778579522},{"date":"2022-10-28","current":-12.102991,"twenty":-28.417086,"median":-13.794007,"eighty":-4.716408,"marketCap":1814597044},{"date":"2022-11-04","current":-16.327026,"twenty":-28.417086,"median":-13.971843,"eighty":-4.716408,"marketCap":2447905134},{"date":"2022-11-11","current":-16.029117,"twenty":-28.417086,"median":-14.373731,"eighty":-4.767341,"marketCap":2562577819},{"date":"2022-11-18","current":-15.257677,"twenty":-28.417086,"median":-14.497908,"eighty":-4.79395,"marketCap":2439247519},{"date":"2022-11-25","current":-15.434239,"twenty":-28.417086,"median":-14.724173,"eighty":-4.898255,"marketCap":2467474524},{"date":"2022-12-02","current":-20.888648,"twenty":-28.417086,"median":-14.896404,"eighty":-4.898255,"marketCap":3339471857},{"date":"2022-12-09","current":-20.334515,"twenty":-28.417086,"median":-14.934267,"eighty":-4.898255,"marketCap":3250882487},{"date":"2022-12-16","current":-21.296099,"twenty":-28.417086,"median":-15.271259,"eighty":-4.898255,"marketCap":3404611100},{"date":"2022-12-23","current":-20.043867,"twenty":-28.417086,"median":-15.412018,"eighty":-4.898255,"marketCap":3204416493},{"date":"2022-12-30","current":-20.951124,"twenty":-28.417086,"median":-15.545609,"eighty":-4.898255,"marketCap":3349459875},{"date":"2023-01-06","current":-18.46839,"twenty":-28.417086,"median":-15.702202,"eighty":-6.20404,"marketCap":2952544754},{"date":"2023-01-13","current":-18.280963,"twenty":-28.417086,"median":-16.029117,"eighty":-6.567519,"marketCap":2922580702},{"date":"2023-01-20","current":-19.23983,"twenty":-28.417086,"median":-16.281692,"eighty":-6.731359,"marketCap":3075875054},{"date":"2023-01-27","current":-19.087715,"twenty":-28.417086,"median":-16.637241,"eighty":-6.946485,"marketCap":3051556403},{"date":"2023-02-03","current":-18.66125,"twenty":-28.417086,"median":-17.062014,"eighty":-7.089998,"marketCap":2983377329},{"date":"2023-02-10","current":-17.055894,"twenty":-28.417086,"median":-17.13163,"eighty":-7.187,"marketCap":2726728711},{"date":"2023-02-17","current":-18.096252,"twenty":-28.417086,"median":-17.237888,"eighty":-7.373862,"marketCap":2893050912},{"date":"2023-02-24","current":-16.583251,"twenty":-28.417086,"median":-17.237888,"eighty":-7.712635,"marketCap":2651167190},{"date":"2023-03-03","current":-15.180365,"twenty":-28.417086,"median":-17.237888,"eighty":-7.893661,"marketCap":2840757185},{"date":"2023-03-10","current":-13.578148,"twenty":-28.417086,"median":-17.237888,"eighty":-8.043265,"marketCap":2540928493},{"date":"2023-03-17","current":-14.589708,"twenty":-28.417086,"median":-17.237888,"eighty":-8.219199,"marketCap":2730225272},{"date":"2023-03-24","current":-14.408325,"twenty":-28.417086,"median":-17.237888,"eighty":-8.347465,"marketCap":2696282401},{"date":"2023-03-31","current":-14.343213,"twenty":-28.415355,"median":-17.237888,"eighty":-8.438189,"marketCap":2684097781},{"date":"2023-04-06","current":-13.582799,"twenty":-28.415355,"median":-17.237888,"eighty":-8.515067,"marketCap":2541798823},{"date":"2023-04-14","current":-15.126881,"twenty":-28.417086,"median":-17.237888,"eighty":-8.590342,"marketCap":2830748390},{"date":"2023-04-21","current":-16.577945,"twenty":-28.417086,"median":-17.237888,"eighty":-8.633548,"marketCap":3102291356},{"date":"2023-04-28","current":-16.560131,"twenty":-28.417086,"median":-17.237888,"eighty":-8.782049,"marketCap":3098957798},{"date":"2023-05-05","current":-16.557804,"twenty":-28.417086,"median":-17.237888,"eighty":-8.912326,"marketCap":3098522307},{"date":"2023-05-12","current":-21.39324,"twenty":-28.417086,"median":-17.328154,"eighty":-9.013947,"marketCap":3395527537},{"date":"2023-05-19","current":-21.103076,"twenty":-28.417086,"median":-17.513874,"eighty":-9.093997,"marketCap":3349472883},{"date":"2023-05-26","current":-18.692708,"twenty":-28.417086,"median":-17.629041,"eighty":-9.135139,"marketCap":2966900073},{"date":"2023-06-02","current":-19.97476,"twenty":-28.417086,"median":-17.77844,"eighty":-9.187407,"marketCap":3170386977},{"date":"2023-06-09","current":-20.655593,"twenty":-28.417086,"median":-17.924982,"eighty":-9.24781,"marketCap":3278448546},{"date":"2023-06-16","current":-23.233424,"twenty":-28.417086,"median":-18.014352,"eighty":-9.337052,"marketCap":3687601016},{"date":"2023-06-23","current":-24.803733,"twenty":-28.418818,"median":-18.297839,"eighty":-9.445345,"marketCap":3936839794},{"date":"2023-06-30","current":-20.073591,"twenty":-28.420549,"median":-18.46839,"eighty":-9.469338,"marketCap":3186073334},{"date":"2023-07-07","current":-20.290469,"twenty":-28.420549,"median":-18.576208,"eighty":-9.560131,"marketCap":3220496172},{"date":"2023-07-14","current":-20.040647,"twenty":-28.420549,"median":-18.698313,"eighty":-9.653222,"marketCap":3180844549},{"date":"2023-07-21","current":-20.433224,"twenty":-28.420549,"median":-18.862469,"eighty":-9.751865,"marketCap":3243154243},{"date":"2023-07-28","current":-21.245831,"twenty":-28.420549,"median":-18.946466,"eighty":-9.838866,"marketCap":3372130954},{"date":"2023-08-04","current":-20.666574,"twenty":-28.420549,"median":-19.022523,"eighty":-9.919098,"marketCap":3280191474},{"date":"2023-08-11","current":-18.037146,"twenty":-28.420549,"median":-19.022523,"eighty":-9.959731,"marketCap":3326963385},{"date":"2023-08-18","current":-17.717339,"twenty":-28.420549,"median":-19.022523,"eighty":-10.057126,"marketCap":3267974672},{"date":"2023-08-25","current":-19.290792,"twenty":-28.420549,"median":-19.061023,"eighty":-10.126968,"marketCap":3558199138},{"date":"2023-09-01","current":-20.672361,"twenty":-28.420549,"median":-19.094946,"eighty":-10.228966,"marketCap":3813030376},{"date":"2023-09-08","current":-20.830985,"twenty":-28.420549,"median":-19.19834,"eighty":-10.246301,"marketCap":3842288777},{"date":"2023-09-15","current":-19.495469,"twenty":-28.420549,"median":-19.262328,"eighty":-10.349328,"marketCap":3595951914},{"date":"2023-09-22","current":-19.119375,"twenty":-28.420549,"median":-19.262328,"eighty":-10.378868,"marketCap":3526581188},{"date":"2023-09-29","current":-18.692112,"twenty":-28.420549,"median":-19.262328,"eighty":-10.440043,"marketCap":3447772268},{"date":"2023-10-06","current":-17.23379,"twenty":-28.420549,"median":-19.262328,"eighty":-10.525456,"marketCap":3178783739},{"date":"2023-10-13","current":-17.016321,"twenty":-28.420549,"median":-19.262328,"eighty":-10.598456,"marketCap":3138671414},{"date":"2023-10-20","current":-16.438109,"twenty":-28.420549,"median":-19.262328,"eighty":-10.646711,"marketCap":3032019822},{"date":"2023-10-27","current":-16.386939,"twenty":-28.429835,"median":-19.282946,"eighty":-10.674305,"marketCap":3022581628},{"date":"2023-11-03","current":-16.476485,"twenty":-28.429835,"median":-19.282946,"eighty":-10.808289,"marketCap":3039098468},{"date":"2023-11-10","current":-14.081381,"twenty":-28.429835,"median":-19.282946,"eighty":-10.929836,"marketCap":2842011992},{"date":"2023-11-17","current":-13.999321,"twenty":-28.429835,"median":-19.282946,"eighty":-11.058288,"marketCap":2825450151},{"date":"2023-11-24","current":-14.665174,"twenty":-28.429835,"median":-19.282946,"eighty":-11.129652,"marketCap":2959837664},{"date":"2023-12-01","current":-15.814005,"twenty":-28.429835,"median":-19.282946,"eighty":-11.282106,"marketCap":3191703445},{"date":"2023-12-08","current":-16.46579,"twenty":-28.426058,"median":-19.282946,"eighty":-11.336853,"marketCap":3323251785},{"date":"2023-12-15","current":-17.178534,"twenty":-28.426058,"median":-19.282946,"eighty":-11.380162,"marketCap":3467103208},{"date":"2023-12-22","current":-16.993315,"twenty":-28.426058,"median":-19.282946,"eighty":-11.419937,"marketCap":3429720766},{"date":"2023-12-29","current":-18.667325,"twenty":-28.429835,"median":-19.282946,"eighty":-11.503011,"marketCap":3767582332},{"date":"2024-01-05","current":-19.222984,"twenty":-28.433613,"median":-19.282946,"eighty":-11.566713,"marketCap":3879729658},{"date":"2024-01-12","current":-20.245209,"twenty":-28.433613,"median":-19.306357,"eighty":-11.683287,"marketCap":4086042883},{"date":"2024-01-19","current":-19.811466,"twenty":-28.43739,"median":-19.389342,"eighty":-11.809472,"marketCap":3998501721},{"date":"2024-01-26","current":-21.239299,"twenty":-28.433613,"median":-19.465893,"eighty":-11.861401,"marketCap":4286677762},{"date":"2024-02-02","current":-21.909841,"twenty":-28.433613,"median":-19.601888,"eighty":-11.983144,"marketCap":4422011667},{"date":"2024-02-09","current":-22.432676,"twenty":-28.433613,"median":-19.675324,"eighty":-12.075057,"marketCap":4527534256},{"date":"2024-02-16","current":-21.912185,"twenty":-28.433613,"median":-19.76274,"eighty":-12.186969,"marketCap":4422484862},{"date":"2024-02-23","current":-15.927086,"twenty":-28.433613,"median":-19.76274,"eighty":-12.293238,"marketCap":3810364180},{"date":"2024-03-01","current":-16.115026,"twenty":-28.429835,"median":-19.739727,"eighty":-12.506682,"marketCap":3855326637},{"date":"2024-03-08","current":-14.265501,"twenty":-28.429835,"median":-19.739727,"eighty":-12.677006,"marketCap":3412849975},{"date":"2024-03-15","current":-13.810051,"twenty":-28.429835,"median":-19.739727,"eighty":-12.869437,"marketCap":3303888912},{"date":"2024-03-22","current":-16.012055,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3830691962},{"date":"2024-03-28","current":-15.677398,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3750629268},{"date":"2024-04-05","current":-14.291244,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3419008643},{"date":"2024-04-12","current":-14.204114,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3398163918},{"date":"2024-04-19","current":-13.014002,"twenty":-28.433613,"median":-19.76274,"eighty":-12.929817,"marketCap":3113443925},{"date":"2024-04-26","current":-14.16253,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3388215300},{"date":"2024-05-03","current":-14.728134,"twenty":-28.429835,"median":-19.739727,"eighty":-12.938558,"marketCap":3523529410},{"date":"2024-05-10","current":-11.807571,"twenty":-28.429835,"median":-19.701371,"eighty":-12.750063,"marketCap":3499492533},{"date":"2024-05-17","current":-12.395706,"twenty":-28.429835,"median":-19.649302,"eighty":-12.578012,"marketCap":3673802218},{"date":"2024-05-24","current":-11.887699,"twenty":-28.429835,"median":-19.525695,"eighty":-12.436014,"marketCap":3523240446},{"date":"2024-05-31","current":-11.892506,"twenty":-28.429835,"median":-19.442778,"eighty":-12.367228,"marketCap":3524665321},{"date":"2024-06-07","current":-11.980646,"twenty":-28.429835,"median":-19.343656,"eighty":-12.253794,"marketCap":3550788026},{"date":"2024-06-14","current":-11.620073,"twenty":-28.433613,"median":-19.298009,"eighty":-12.177866,"marketCap":3443922415},{"date":"2024-06-21","current":-12.047953,"twenty":-28.43739,"median":-19.272637,"eighty":-12.168336,"marketCap":3570736273},{"date":"2024-06-28","current":-12.834804,"twenty":-28.441192,"median":-19.23983,"eighty":-12.143826,"marketCap":3803940784},{"date":"2024-07-05","current":-12.854035,"twenty":-28.441192,"median":-19.19834,"eighty":-12.143826,"marketCap":3809640283},{"date":"2024-07-12","current":-13.549541,"twenty":-28.441192,"median":-19.087715,"eighty":-12.143826,"marketCap":4015772172},{"date":"2024-07-15","current":-13.273902,"twenty":-28.441192,"median":-19.07844,"eighty":-12.143826,"marketCap":3934079350},{"date":"2024-08-02","current":-13.783512,"twenty":-28.490495,"median":-18.952635,"eighty":-12.102991,"marketCap":4085116080},{"date":"2024-08-09","current":-13.223111,"twenty":-28.490495,"median":-18.859161,"eighty":-12.102991,"marketCap":4080017425},{"date":"2024-08-16","current":-13.318007,"twenty":-28.490495,"median":-18.73003,"eighty":-12.102991,"marketCap":4109297550},{"date":"2024-08-23","current":-13.551356,"twenty":-28.490495,"median":-18.673323,"eighty":-12.102991,"marketCap":4181297857},{"date":"2024-08-30","current":-13.862488,"twenty":-28.490495,"median":-18.56764,"eighty":-12.102991,"marketCap":4277298267},{"date":"2024-09-06","current":-14.57498,"twenty":-28.490495,"median":-18.506355,"eighty":-12.102991,"marketCap":4497139206},{"date":"2024-09-13","current":-14.273182,"twenty":-28.490495,"median":-18.365921,"eighty":-12.102991,"marketCap":4404018808},{"date":"2024-09-20","current":-14.672987,"twenty":-28.490495,"median":-18.269068,"eighty":-12.102991,"marketCap":4527379335},{"date":"2024-09-27","current":-13.944938,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4302738376},{"date":"2024-10-04","current":-14.184509,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":4376658691},{"date":"2024-10-11","current":-12.924425,"twenty":-28.490495,"median":-18.102517,"eighty":-12.102991,"marketCap":3987857031},{"date":"2024-10-18","current":-14.522087,"twenty":-28.490495,"median":-18.096122,"eighty":-12.102991,"marketCap":4480819136},{"date":"2024-10-25","current":-13.818929,"twenty":-28.490495,"median":-18.063615,"eighty":-12.102991,"marketCap":4263858210},{"date":"2024-10-31","current":-13.916936,"twenty":-28.490495,"median":-18.025749,"eighty":-12.102991,"marketCap":4294098339},{"date":"2024-11-08","current":-14.109838,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4353618593},{"date":"2024-11-15","current":-15.175127,"twenty":-28.4958,"median":-17.957834,"eighty":-12.097778,"marketCap":4718781551},{"date":"2024-11-22","current":-15.302924,"twenty":-28.4958,"median":-17.88108,"eighty":-12.097778,"marketCap":4758520699},{"date":"2024-11-29","current":-15.307599,"twenty":-28.4958,"median":-17.77844,"eighty":-12.097778,"marketCap":4759974570},{"date":"2024-12-06","current":-15.32786,"twenty":-28.449873,"median":-17.629041,"eighty":-12.097778,"marketCap":4766274679},{"date":"2024-12-13","current":-14.707576,"twenty":-28.320039,"median":-17.452847,"eighty":-12.097778,"marketCap":4573394423},{"date":"2024-12-20","current":-13.98599,"twenty":-28.091929,"median":-17.328154,"eighty":-12.097778,"marketCap":4349013622},{"date":"2024-12-27","current":-13.710136,"twenty":-27.950529,"median":-17.237888,"eighty":-12.097778,"marketCap":4263235216},{"date":"2025-01-03","current":-13.608833,"twenty":-27.778537,"median":-17.194427,"eighty":-12.097778,"marketCap":4231734672},{"date":"2025-01-10","current":-12.868545,"twenty":-27.620773,"median":-17.134813,"eighty":-12.092564,"marketCap":4001538386},{"date":"2025-01-17","current":-14.601598,"twenty":-27.401353,"median":-17.062407,"eighty":-12.092564,"marketCap":4540440007},{"date":"2025-01-24","current":-16.19127,"twenty":-27.316594,"median":-17.006543,"eighty":-12.092564,"marketCap":5034756242},{"date":"2025-01-31","current":-16.964286,"twenty":-27.062663,"median":-16.935586,"eighty":-12.092564,"marketCap":5275129627},{"date":"2025-02-07","current":-17.065589,"twenty":-26.869288,"median":-16.889297,"eighty":-12.092564,"marketCap":5306630172},{"date":"2025-02-14","current":-20.522345,"twenty":-26.613063,"median":-16.886581,"eighty":-12.092564,"marketCap":6381525671},{"date":"2025-02-21","current":-21.919439,"twenty":-26.428477,"median":-16.886581,"eighty":-12.092564,"marketCap":6295613527},{"date":"2025-02-28","current":-21.462713,"twenty":-26.259509,"median":-16.886581,"eighty":-12.092564,"marketCap":6164434593},{"date":"2025-03-07","current":-21.12314,"twenty":-25.773705,"median":-16.884764,"eighty":-12.087351,"marketCap":6066903787},{"date":"2025-03-14","current":-20.654529,"twenty":-25.461185,"median":-16.884764,"eighty":-12.087351,"marketCap":5932311274},{"date":"2025-03-21","current":-21.438943,"twenty":-25.440831,"median":-16.884764,"eighty":-12.087351,"marketCap":6157607436},{"date":"2025-03-28","current":-20.674904,"twenty":-25.12508,"median":-16.884764,"eighty":-12.087351,"marketCap":5938163123},{"date":"2025-04-04","current":-18.318267,"twenty":-24.742094,"median":-16.884764,"eighty":-12.087351,"marketCap":5261299329},{"date":"2025-04-11","current":-16.24008,"twenty":-24.602553,"median":-16.762118,"eighty":-12.092564,"marketCap":4664410796},{"date":"2025-04-17","current":-17.737597,"twenty":-24.358761,"median":-16.744642,"eighty":-12.092564,"marketCap":5094521651},{"date":"2025-04-25","current":-17.897196,"twenty":-23.915799,"median":-16.742979,"eighty":-12.087351,"marketCap":5140361130},{"date":"2025-05-02","current":-19.234219,"twenty":-23.617891,"median":-16.742979,"eighty":-12.087351,"marketCap":5524375578},{"date":"2025-05-09","current":-19.261265,"twenty":-23.314094,"median":-16.742979,"eighty":-12.087351,"marketCap":5359870693},{"date":"2025-05-16","current":-19.025033,"twenty":-23.105255,"median":-16.742979,"eighty":-12.087351,"marketCap":5294133855},{"date":"2025-05-23","current":-18.515782,"twenty":-22.831967,"median":-16.742979,"eighty":-12.087351,"marketCap":5152423687},{"date":"2025-05-30","current":-18.567239,"twenty":-22.597152,"median":-16.742979,"eighty":-12.087351,"marketCap":5166742833},{"date":"2025-06-06","current":-19.635423,"twenty":-22.218917,"median":-16.742979,"eighty":-12.087351,"marketCap":5463988550},{"date":"2025-06-13","current":-18.852917,"twenty":-22.04462,"median":-16.742979,"eighty":-12.087351,"marketCap":5246238781},{"date":"2025-06-18","current":-18.027824,"twenty":-21.978884,"median":-16.742979,"eighty":-12.087351,"marketCap":5016638684}],"updateTime":1750418343765}}}